 NEW YORK--BUSINESS WIRE--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Intersect ENT, Inc. NASDAQ: XENT to Medtronic plc for 28.25 per share is fair to Intersect ENT shareholders. Halper Sadeh encourages Intersect ENT shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at 212 763-0060 or or The investigation concerns whether Inters 